A Guide to Drug Classifications and Dosage Calculations,
4th Edition by Cynthia J. Watkins
Chapters 1 - 21
,
,Chapter G 1. G History G of G Pharmacology
Pharmacology GClear Gand GSimple- GA GGuide Gto GDrug GClassifications Gand GDosage
GCalculations G4thGEdition GWatkins GTest GBank
1. A G nurse G working G in G radiology G administers G iodine G to G a G patient G who G is G having G a
GcomputedGtomography G (CT) G scan. G The G nurse G working G on G the G oncology G unit
Gadministers Gchemotherapy G to G patients G who G have G cancer. G At G the G Public G Health
GDepartment, G a G nurse Gadministers G a G measles-mumps-rubella G (MMR) G vaccine Gto
Ga G 14-month-old Gchild G as G a Groutine G immunization. G Which Gbranch G of
Gpharmacology Gbest G describes Gthe Gactions Gof Gall Gthree Gnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology Gis G the G study G of G the G biologic G effects G of G chemicals. G Nurses G are
Ginvolved Gwith G clinical G pharmacology G or G pharmacotherapeutics, G which G is G a
Gbranch G of Gpharmacology G that G deals G with G the G uses G of G drugs G to G treat, G prevent,
Gand G diagnose G disease.GThe G radiology G nurse G is G administering G a G drug G to G help
Gdiagnose G a G disease. G The G oncology Gnurse G is G administering G a G drug G to G help G treat
Ga G disease. G Pharmacoeconomics G includes G any Gcosts G involved G in G drug G therapy.
GPharmacodynamics G involves Ghow Ga G drug Gaffects G the Gbody Gand Gpharmacokinetics
Gis Ghow Gthe Gbody Gacts Gon Gthe Gbody.
2. A Gphysician G has Gordered G intramuscular G (IM) Ginjections G of Gmorphine, Ga
Gnarcotic, Gevery G4 G hours G as G needed G for G pain G in Ga G motor G vehicle
G accident Gvictim. G The G nurse G is G aware G this G drug G has G a G high G abuse
G potential. G Under G whatGcategory Gwould Gmorphine Gbe Gclassified?
A) Schedule G I
B) Schedule GII
C) Schedule G III
D) Schedule GIV
ANSWER: B
, Feedback:
Narcotics Gwith Ga Ghigh G abuse G potential Gare Gclassified Gas GSchedule GII
Gdrugs Gbecause G of G severe G dependence G liability. G Schedule G I Gdrugs G have
G high G abuse Gpotential G and G no G accepted G medical G use. G Schedule G III
G drugs G have G a G lesser Gabuse G potential G than G II G and G an G accepted G medical
G use. G Schedule G IV G drugs G haveGlow Gabuse Gpotential Gand Glimited
G dependence Gliability.
3. When G involved G in G phase G III G drug G evaluation G studies, G what
G responsibilitiesGwould Gthe Gnurse Ghave?
A) Working G with G animals G who G are G given G experimental G drugs
B) Choosing G appropriate G patients G to G be G involved G in G the G drug G study
C) Monitoring G and G observing G patients G closely G for G adverse G effects
D) Conducting G research G to G determine G effectiveness G of G the G drug
ANSWER: C
Feedback:
Phase G III G studies G involve G use G of G a G drug Gin G a G vast G clinical G population
G in G whichGpatients G are G asked G to G record G any G symptoms G they G experience
G while G taking G theGdrugs. G Nurses G may Gbe G responsible G for G helping G collect
G and G analyze G the Ginformation G to G be G shared G with G the G Food G and G Drug
G Administration G (FDA) G butGwould G not G conduct G research G independently
G because G nurses G do G not G prescribe Gmedications. G Use G of G animals G in G drug
G testing G is G done G in G the G preclinical G trials. GSelect G patients G who G are
G involved G in G phase G II G studies G to G participate G in G studies Gwhere G the
G participants G have G the G disease G the G drug G is G intended G to G treat. G These
Gpatients G are G monitored G closely G for G drug G action G and G adverse G effects.
G Phase G I Gstudies G involve G healthy G human G volunteers G who G are G usually
Gpaid G for G their Gparticipation. G Nurses Gmay Gobserve G for G adverse Geffects
G and G toxicity.
4. What G concept G is G considered G when G generic G drugs G are G substituted
G for G brandGname Gdrugs?
A) Bioavailability
B) Critical G concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback: